Shareholding structure
CANCER RESEARCH TECHNOLOGY LTD
Company number 01626049 · United Kingdom
CANCER RESEARCH TECHNOLOGY LTD holds shares in 27 companies directly, and in 1 more through them, across 2 layers of ownership.
Compiled using data from Companies House, OpenRegistry and Bloomberg.
- Companies in the structure
- 28
- Layers
- 2
- Held directly
- 27
- Wholly owned directly
- 0
- The company this page is about
- Holds shares in companies below it
- Holds no further companies here
- List of companies that hold no further companies
- 60%Economic interest held by the company above
- 1,000 sharesShares held
COMPANY
LAYER 127 companies
LAYER 21 company
- CANCER RESEARCH TECHNOLOGY LTDCompany number 01626049United Kingdom
- 0 sharesAKAMIS BIO LIMITED06001442
- HYBRID BIOSYSTEMS LIMITED03421781
26 companies held by CANCER RESEARCH TECHNOLOGY LTD
- STRATOSVIR LIMITED13099988 · 12.7%
- ZYGOSITY LIMITED12760444 · 10.9%
- CELLINTA LTD12161294 · 8.5%
- NK:IO LTD12479455 · 7.9%
- VERINNOGEN LIMITED13266666 · 7.4%
- 52 NORTH HEALTH LTD11460425 · 4.5%
- MOSAIC THERAPEUTICS LIMITED12780154 · 2.1%
- NUCLEARMEDIX LIMITED16134861 · 1.1%
- BIOCAPTIVA LIMITEDSC609101 · 0.8%
- GENOME THERAPEUTICS LTD12392992 · 0.5%
- CYTED LTD11478299 · 0.4%
- SIFTR BIO LIMITED15665818 · 0.3%
- ARTIOS PHARMA LIMITED09931309 · 3,750,000 shares
- ELAITRA LTD11317171 · 69,068 shares
- ENEDRA THERAPEUTICS LIMITED13433538 · 16,842 shares
- EPSILOGEN LTD10295520 · 600,000 shares
- GAMMADELTA THERAPEUTICS LTD10238425 · 0 shares
- INFINITOPES LIMITED13642685 · 741,362 shares
- MANTRA DIAGNOSTICS LIMITED13040292 · 1,320 shares
- MISSION THERAPEUTICS LIMITED07630933 · 283,500 shares
- MYRICX PHARMA LIMITED12082645 · 527,415 shares
- NEOBE THERAPEUTICS LTD13146056 · 22,231 shares
- OLIGOTUNE LTD15373740 · 21,364 shares
- SPLICEOR LTD12826144 · 25,106 shares
- STORM THERAPEUTICS LIMITED09553473 · 100,000 shares
- TROGENIX LTD14930146 · 3,500 shares
- 0 shares
Scroll sideways to see the whole chart.